The Baltimore Sun
May 26, 2020
By: Larry Zarzecki and Jessica Gorski


“We can no longer wait and hope that pharmaceutical corporations will do the right thing and price prescription drugs fairly. We urge Maryland legislators to override this veto in the next General Assembly session so that the Prescription Drug Affordability Board has the resources needed to take action to make expensive medications more affordable for Maryland families.”

Read the full article.

Last modified: May 26, 2020